[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR028281A1 - DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA - Google Patents

DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA

Info

Publication number
AR028281A1
AR028281A1 ARP010101373A ARP010101373A AR028281A1 AR 028281 A1 AR028281 A1 AR 028281A1 AR P010101373 A ARP010101373 A AR P010101373A AR P010101373 A ARP010101373 A AR P010101373A AR 028281 A1 AR028281 A1 AR 028281A1
Authority
AR
Argentina
Prior art keywords
pirimidona
derivatives
heteroaroarilalquilamino
arilalquilamino
Prior art date
Application number
ARP010101373A
Other languages
Spanish (es)
Original Assignee
Sanofi Synthelabo
Mitsubishi Tokyo Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000081938A external-priority patent/JP2001270884A/en
Priority claimed from EP00400805A external-priority patent/EP1136099A1/en
Priority claimed from EP00400806A external-priority patent/EP1136491A1/en
Priority claimed from EP00400804A external-priority patent/EP1136484A1/en
Application filed by Sanofi Synthelabo, Mitsubishi Tokyo Pharm Inc filed Critical Sanofi Synthelabo
Publication of AR028281A1 publication Critical patent/AR028281A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010101373A 2000-03-23 2001-03-23 DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA AR028281A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000081938A JP2001270884A (en) 2000-03-23 2000-03-23 Pyrimidone derivative
EP00400805A EP1136099A1 (en) 2000-03-23 2000-03-23 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors
EP00400806A EP1136491A1 (en) 2000-03-23 2000-03-23 2-[(Heteroaryl)alkylamino]pyrimidone derivatives
EP00400804A EP1136484A1 (en) 2000-03-23 2000-03-23 2-(Arylalkylamino)pyrimidone derivatives

Publications (1)

Publication Number Publication Date
AR028281A1 true AR028281A1 (en) 2003-04-30

Family

ID=27440051

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101373A AR028281A1 (en) 2000-03-23 2001-03-23 DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA

Country Status (3)

Country Link
AR (1) AR028281A1 (en)
AU (1) AU2001248365A1 (en)
WO (1) WO2001070727A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197621C (en) 2000-04-26 2005-04-20 卫材株式会社 Medicinal compositions promoting bowel movement
TWI335221B (en) * 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
TWI301834B (en) * 2001-10-22 2008-10-11 Eisai R&D Man Co Ltd Pyrimidone compound and pharmaceutical composition including the same
TWI330183B (en) 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
US20050203059A1 (en) * 2002-03-01 2005-09-15 Harrison Stephen D. Methods and compositions for treatment of ischemia
EP1925306A3 (en) * 2002-04-30 2008-09-17 Alcon, Inc. Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure
PL378030A1 (en) 2002-04-30 2006-02-20 Alcon, Inc. Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
WO2004037791A1 (en) 2002-10-21 2004-05-06 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1713793A4 (en) * 2004-02-04 2009-09-02 Smithkline Beecham Corp Pyrimidinone compounds useful as kinase inhibitors
CA2593612A1 (en) 2005-01-07 2006-07-13 Emory University Cxcr4 antagonists for the treatment of hiv infection
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
JP2009513672A (en) 2005-10-31 2009-04-02 ブレインセルス,インコーポレイティド GABA receptor-mediated regulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009543802A (en) * 2006-07-11 2009-12-10 エモリー・ユニバーシテイ CXCR4 antagonists containing diazine and triazine structures for the treatment of medical diseases
JP2009543874A (en) * 2006-07-18 2009-12-10 ユニバーシティー オブ ロチェスター Thiazolidinone derivatives
WO2008023239A1 (en) * 2006-08-23 2008-02-28 Pfizer Products Inc. Pyrimidone compounds as gsk-3 inhibitors
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CN101917980B (en) * 2007-11-01 2013-12-11 奥克塞拉有限公司 Amine derivative compounds for treating ophthalmic diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514195A (en) * 1996-12-05 2002-05-14 アムジエン・インコーポレーテツド Substituted pyrimidine compounds and uses thereof

Also Published As

Publication number Publication date
WO2001070727A1 (en) 2001-09-27
AU2001248365A1 (en) 2001-10-03

Similar Documents

Publication Publication Date Title
AR028281A1 (en) DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA
AR028567A1 (en) NEW DERIVATIVES OF FENIL-PROPARGILETER
AR028596A1 (en) NEW DERIVATIVES OF PHENYLGLYCIN
NO20025978L (en) Benzothiazole derivatives
ID30590A (en) ONCE USE SHORT TYPE OF SHORT-PANTS
AR028253A1 (en) INHIBITORS OF THE GLUCOGENO FOSFORILASA
MA27126A1 (en) 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES
AR027938A1 (en) URACILO COMPOUNDS AND USE OF THE SAME
DE60134338D1 (en) PIPERAZIN DERIVATIVES
DK1292604T3 (en) 2-aminocarbonyl-9H-purine derivatives
DE60043343D1 (en) CHROME DERIVATIVES
DE50112013D1 (en) DEODORANTIA AND ANTIPERSPIRANTIES
ID30187A (en) DONGKRAK KIND OF PANTAGRAF
ATE298332T1 (en) DECAHYDRO-ISOCHINOLINE DERIVATIVES
DK1280809T3 (en) Antitumorecteinascidin derivatives
AR028602A1 (en) PIRROL DERIVATIVES
PT1246817E (en) DERIVATIVES OF 4-PHENYL-1-PIPERAZINYL, -PIPERIDINYL E-TETRAHYDROPYRIDYL
PT1322592E (en) SUBSTITUTED DERIVATIVES OF 1-AMINOBUTAN-3-OL
DE60032898D1 (en) ARYLTHIAZOLIDEINDION AND ARYLOXAZOLIDINE DERIVATIVES
DE60117096D1 (en) DIHYDROINDOL AND TETRAHYDROCHINOLINE DERIVATIVES
ATE280752T1 (en) AMINOMETHYL-PHENYL-CYCLOHEXANONE DERIVATIVES
PT1178984E (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME
PT1392670E (en) SUBSTITUTED DERIVATIVES OF C-FURAN-2-IL-METHYLAMINE AND C-THIOFEN-2-IL-METHYLAMINE
AR027964A1 (en) COMBINATION OF THERMOPLASTIC EPNXIC FIBERS AND DERIVATIVES
DE60007360T2 (en) AMORPHE MODIFICATION OF TORASEMID

Legal Events

Date Code Title Description
FB Suspension of granting procedure